ARSI doublet therapy induced deeper and faster PSA responses compared with combined androgen blockade in men with mCSPC. Response rates to androgen receptor signaling inhibitors (ARSIs) in metastatic ...
Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort—Results from the Canary/EDRN Prostate Active Surveillance Study. Background: MDV3100, a ...
Activity of lutetium-177 PSMA (Lu-PSMA) and determinants of outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with cabazitaxel: The PACAP study. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results